OR WAIT null SECS
March 24, 2022
Roquette is investing €25 million at its site in Lestrem, France to strengthen its position in the polyols market.
Recro Pharma changed its name to Societal CDMO to reflect the company’s expansion as a result of the acquisition of IriSys.
Teva has reached an agreement with the Attorney General of Rhode Island to settle opioid-related claims.
March 23, 2022
FDA has approved RINVOQ as a treatment for adults with moderately to severely active ulcerative colitis who have not had an adequate response to existing treatments.
March 21, 2022
FDA has approved Opdualag for adults and pediatric patients 12 years of age and older with unresectable or metastatic melanoma.
FDA has approved ZTALMY as a treatment for seizures associated with CDKL5 deficiency disorder (CDD).
Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine.
Olympia Pharmacy is voluntarily recalling eleven lots of seven compounded products due to out-of-specification results.
Moderna, Pfizer, and BioNTech are seeking FDA approval for a fourth dose of their respective COVID-19 vaccines.
physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.